Search

Your search keyword '"Serena Ludovisi"' showing total 41 results

Search Constraints

Start Over You searched for: Author "Serena Ludovisi" Remove constraint Author: "Serena Ludovisi"
41 results on '"Serena Ludovisi"'

Search Results

1. Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy

2. Host genetics and COVID-19 severity: increasing the accuracy of latest severity scores by Boolean quantum features

3. Anti-spike antibodies and neutralising antibody activity in people living with HIV vaccinated with COVID-19 mRNA-1273 vaccine: a prospective single-centre cohort study

5. Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study

6. Vaccination with COVID-19 mRNA-1273 is not associated with HIV-RNA blips among people with HIV on ART: a retrospective cohort study

7. Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorder

8. Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19

9. An explainable model of host genetic interactions linked to COVID-19 severity

10. The obesity paradox: Analysis from the SMAtteo COvid-19 REgistry (SMACORE) cohort

11. An explainable model of host genetic interactions linked to COVID-19 severity

12. Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity

13. A challenging case of SARS-CoV-2- AIDS and Nocardiosis coinfection from the SMatteo COvid19 REgistry (SMACORE)

14. SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues

15. Transient increase in plasma HIV RNA after COVID-19 vaccination with mRNA-1272

16. Author response: Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study

17. Anti-Spike Antibodies and Neutralising Antibody Activity in People Living with HIV Vaccinated with COVID-19 mRNA-1273 Vaccine: A Prospective Cohort Study

18. Genetic mechanisms of critical illness in COVID-19

19. Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males

20. Unique immunological profile in patients with COVID-19

21. Expansion of atypical memory B cells is a prominent feature of COVID-19

22. Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital

23. Running out of bullets: the challenging management of acute hepatitis and SARS‐COV‐2 from the SMatteo COvid19 Registry (SMACORE)

24. Unique Immunological Profile In Patients With COVID-19

25. Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): Rationale and feasibility of a shared pragmatic protocol

26. Patients with chronic hepatitis C receiving treatment with direct acting antivirals: How is this population changing?

27. Nutritional parameters associated with prognosis in non-critically ill hospitalized covid-19 patients: the nutri-covid19 study

28. Hepatitis C virus inhibits CD4 T cell function via binding to Toll-like receptor 7

29. Adaptive Natural Killer Cell Functional Recovery in Hepatitis C Virus Cured Patients

30. Epidemiological characteristics of bloodstream infections in patients with different degrees of liver disease

31. Hepatitis C virus-induced NK cell activation causes metzincin-mediated CD16 cleavage and impaired antibody-dependent cytotoxicity

32. Lack of Siglec-7 expression identifies a dysfunctional natural killer cell subset associated with liver inflammation and fibrosis in chronic HCV infection

33. Infective endocarditis in patients with hepatic diseases

34. Efficacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: Phase II clinical trial and systematic review

35. Skewed B cells in chronic hepatitis C virus infection maintain their ability to respond to virus-induced activation

36. Performance of real-time strain elastography, transient elastography, and aspartate-to-platelet ratio index in the assessment of fibrosis in chronic hepatitis C

37. Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infection

38. A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection

39. Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infections

41. Performance of liver stiffness measurements by transient elastography in chronic hepatitis

Catalog

Books, media, physical & digital resources